Attema, A.E. & Brouwer, W.B.F. (2014). Constant proportional trade-offs and health state evaluations. In AC Michalos (Ed.), Encyclopedia of Quality of Life and Well-Being Research (pp. 1207-1212). Dordrecht: Springer.
Attema, A.E. & Brouwer, W.B.F. (2014). Deriving time discounting correction factors for TTO tariffs. Health Economics, 23 (4), 410-425. doi: http://dx.doi.org/10.1002/hec.2921
Attema, A.E., Brouwer, W.B.F. & Exel, N.J.A. van (2014). Your right arm for a publication in AER? Economic Inquiry, 52 (1), 495-502. doi: http://dx.doi.org/10.1111/ecin.12013
Blommestein, H.M., Franken, M.G., Verelst, S.G.R., Agthoven, M. van, Huijgens, P.C. & Uyl – de Groot, C.A. (2014). Access to expensive cancer drugs in Dutch daily practice: Should we be concerned? Netherlands Journal of Medicine, 72 (4), 235-241.
Blommestein, H.M., Issa, DE, Pompen, M., Ten Hoor, G., Hogendoorn, M., Joosten, P., Zweegman, S., Huijgens, P.C. & Uyl – de Groot, C.A. (2014). Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study. European Journal of Haematology, 92, 398-406. doi: http://dx.doi.org/10.1111/ejh.12264
Boland, M.R.S., Van Boven, J.F.M., Kocks, J.W., Van der Molen, T., Goossens, L.M., Chavannes, NH & Rutten – van Molken, M.P.M.H. (2014). Mapping the clinical Chronic Obstructive Pulmonary Disease questionnaire (CCQ) onto generic preference-based EQ-5D values. Value in Health.
Bonfrer, I.E.J., Poel, E. van de & Doorslaer, E.K.A. van (2014). The effects of performance incentives on the utilization and quality of maternal and child care in Burundi. Social Science & Medicine, 123, 96-104.
Bonfrer, I.E.J., Soeters, R., Poel, E. van de, Basenga, O., Longin, G., Looij, F. Van de & Doorslaer, E.K.A. van (2014). Introduction of Performance Based Financing in Burundi associated with improvements in care and quality. Health Affairs, 33 (12), 2179-2188.
Bosch, L.M.C. v.d., Sinnaeve, PR, Hakkaart-van Roijen, L. & Furth, E Van (2014). Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial. Trials, 15 (152). doi: http://dx.doi.org/10.1186/1745-6215-15-152
Bouwmans, C.A.M., Vemer, P., van Straten, A., Tan, S.S., Rutten, F.F.H. & Hakkaart, L (2014). Health Related Quality-of-Life and productivity-losses in patients with depression and anxiety disorders. Journal of Occupational and Environmental Medicine, 56 (4), 420-424. doi: http://dx.doi.org/10.1097/JOM.0000000000000112
Boven, J.F.M. van, Chavannes, NH, Van der Molen, T., Rutten – van Molken, M.P.M.H., Postma, M.J. & Vegter, S (2014). Clinical and economic impact of non-adherence in COPD: a systematic review. Respiratory Medicine, 108 (1), 103-113. doi: 10.1016/j.rmed.2013.08.044.
Boven, JFM van, Tommelein, E, Boussery, K, Mehuys, E, Vegter, S, Brusselle, G.G.O., Molken, M.P.M.H. van & Postma, M.J. (2014). Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis. Respiratory Research, 15. doi: 10.1186/1465-9921-15-66
Boven, JFM van, Tommelein, E, Boussery, K, Mehuys, E, Vegter, S, Brusselle, G.G.O., Rutten – van Molken, M.P.M.H. & Postma, M.J. (2014). Optimizing pharmacotherapy in patients with COPD by community-pharmacists: a cost-effectiveness analysis. European Respiratory Journal, 3, 15-6.
Brand, CL van den, Linden, M.C.M., Linden, N. van der & Rhemrev, SJ (2014). Fracture prevalence during an unusual period of snow and ice in the Netherlands. International Journal of Emergency Medicine.
Bredenkamp, C., Buisman, L.R. & Poel, E. van de (2014). Persistent inequalities in child undernutrition: Evidence from 80 countries from 1990 to today. International Journal of Epidemiology, 43 (4), 1328-1335. doi: http://dx.doi.org/10.1093/ije/dyu075
Brown, SR, Danielson, S & Exel, N.J.A. van (2014). Overly ambitious critics and the Medici Effect: a reply to Kampen and Tamás. Quality and Quantity. doi: 10.1007/s11135-014-0007-x
Burgers, L.T., Nauta, S.T., Deckers, J.W., Severens, J.L. & Redekop, W.K. (2014). Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment? International Journal of Cardiology, 176 (3), 980-987. doi: 10.1016/j.ijcard.2014.08.134
Burgers, L.T., Redekop, W.K. & Severens, J.L. (2014). Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease. Pharmacoeconomics (Print), 32 (7), 627-637. doi: http://dx.doi.org/10.1007/s40273-014-0155-9
Cramm, J.M., Adams, S.A., Walters, B.H., Tsiachristas, A., Bal, R.A., Huijsman, R., Rutten – van Molken, M.P.M.H. & Nieboer, A.P. (2014). The role of disease management programs in the health behavior of chronically ill patients. Patient Education and Counseling. doi: http://dx.doi.org/10.1016/j.pec.2013.12.017
Elbert, N.J., Os-Medendorp, H van, Renselaar, W van, Ekeland, AG, Roijen, L. van, Raat, H., Nijsten, T.E.C. & Pasmans, S.G.M.A. (2014). Effectiveness and Cost-Effectiveness of eHealth Interventions in Somatic Diseases: A Systematic Review of Systematic Reviews and Meta-Analyses. Journal of Medical Internet Research, 16 (4), 182-204. doi: http://dx.doi.org/10.2196/jmir.2790
Franken, M.G., Gaultney, J.G., Blommestein, H.M., Huijgens, P.C., Sonneveld, P., Redekop, W.K. & Uyl – de Groot, C.A. (2014). Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib? Value in Health, 17, 245-253. doi: http://dx.doi.org/10.1016/j.jval.2013.12.009
Fennema, P., Heyse, T.J. & Uyl – de Groot, C.A. (2014). Cost-effectiveness and clinical implications of advanced bearings in total knee arthroplasty: a long-term modeling analysis. International Journal of Technology Assessment in Health Care, 30 (2), 218-225. doi: 10.1017/S0266462314000129
Fokkema, JP, Scheele, F., Westerman, M., Exel, N.J.A. van, Scherpbier, AJ, Vleuten, C.P.M. van der & Dörr, PJ (2014). Perceived effects of innovations in postgraduate medical education: a Q study focusing on workplace-based assessment. Academic Medicine, 89 (9), 1259-1266. doi: 10.1097/ACM.0000000000000394
Gaultney, J.G., Franken, M.G., Uyl – de Groot, C.A., Redekop, W.K., Huijgens, P.C., Holt, B. van der, Lokhorst, H.M. & Sonneveld, P. (2014). Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement. Health Policy, IN PRESS. doi: http://dx.doi.org/10.1016/j.healthpol.2014.11.010
Goorden, M., Muntingh, A, Marwijk, H.W.J. van, Spinhoven, P., Ader, H, Balkom, A van, Feltz-Cornelis, C van der & Hakkaart-van Roijen, L. (2014). Cost utility analysis of a collaborative stepped care intervention for panic and generalized anxiety disorders in primary care. Journal of Psychosomatic Research, 24 (3), 555-562. doi: http://dx.doi.org/10.1016/j.jpsychores.2014.04.005
Goossens, L.M.A., Leimer, I., Metzdorf, N., Becker, K. & Rutten – van Molken, M.P.M.H. (2014). Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Public Health, 14, 163. doi: 10.1186/1471-2466-14-163.
Goossens, L.M.A., Utens, C.M.A., Smeenk, F.W., Donkers, B., van Schayck, C.P. & Rutten – van Molken, M.P.M.H. (2014). Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home. Value in Health, 17 (5), 588-596. doi: 10.1016/j.jval.2014.05.004.
Grustam, A.S., Severens, J.L., Nijnatten, J van, Koymans, R. & Vrijhoef, H.J.M. (2014). Cost-Effectiveness of telehealth interventions for chronic heart failure patients: a literature review. International Journal of Technology Assessment in Health Care, 59-68. doi: 10.1017/S0266462313000779
Haalen, H.G.M. van, Severens, J.L., Tran-Duy, A. & Boonen, A. (2014). How to Select the Right Cost-Effectiveness Model? : A Systematic Review and Stepwise Approach for Selecting a Transferable Health Economic Evaluation Model for Rheumatoid Arthritis. Pharmacoeconomics (Online). doi: http://dx.doi.org/10.1007/s40273-014-0139-9
Hendriks, M.E., Kundu, P., Boers, A.C., Bolarinwa, O.A., te Pas, M.J., Akande, T.M., Agbede, K., Gomez, G.B., Redekop, W.K., Schultsz, C & Tan, S.S. (2014). Step-by-step Guideline for disease-specific costing studies in low and middle income countries: a mixed methodology. Global Health Action, 28 (7), 23573. doi: http://dx.doi.org/10.3402/gha.v7.23573
Hoefman, R.J., Payakachat, N., Exel, N.J.A. van, Kuhlthau, K.A., Kovacs, E, Pyne, J & Tilford, J.M. (2014). Caring for a child with autism spectrum disorder and parents’ quality of life: application of the CarerQol. Journal of Autism and Developmental Disorders, 44 (8), 1933-1945. doi: 10.1007/s10803-014-2066-1
Hoogendoorn, M., Feenstra, T.L., Asukai, Y, Borg, S. ter, Hansen, RN, Jansson, SA, Samyshkin, Y, Wacker, M, Briggs, AH, Lloyd, A, Sullivan, S.D. & Rutten – van Molken, M.P.M.H. (2014). Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. Value in Health, 17 (5), 525-536.
Hou, Z., Poel, E. van de, Doorslaer, E.K.A. van, Yu, B & Meng, Q. (2014). Effects of NCMS coverage on access to care and financial protection in China. Health Economics, 22 (12). doi: http://dx.doi.org/10.1002/hec.2965
Jansen, L.A.W., Knauff, E.A.H., Tan, S.S. & Lowenberg, M (2014). Estimated hospital health costs of chronic abdominal pain in the Netherlands. Netherlands Journal of Medicine, 72 (2), 102-106.
Kanters, T.A., Hoogenboom-Plug, I, Rutten – van Molken, M.P.M.H., Redekop, W.K., Ploeg, A.T. van der & Hakkaart, L (2014). Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease. Orphanet Journal of Rare Diseases, 9, 75. doi: http://dx.doi.org/doi:10.1186/1750-1172-9-75
Kanters, T.A., Redekop, W.K., Kruijshaar, M.E., Ploeg, A.T. van der, Rutten – van Molken, M.P.M.H. & Hakkaart-van Roijen, L. (2014). Comparison of EQ-5D and SF-6D utilities in Pompe disease. Quality of Life Research. doi: 10.1007/s11136-014-0833-2
van der Kolk, A., Bouwmans, C.A.M., Schawo, S.J., Buitelaar, J.K., van Agthoven, M. & Hakkaart-van Roijen, L. (2014). Association between quality of life and treatment response in children with attention deficit hyperactivity disorder and their parents. The Journal of Mental Health Policy and Economics, 17 (3), 119-129.
Kruis, A.L., Boland, M.R.S., Assendelft, W.J.J., Gussekloo, J, Tsiachristas, A., Stijnen, T., Blom, C., Sont, J.K., Rutten – van Molken, M.P.M.H. & Chavannes, NH (2014). Effectiveness of integrated disease management for primary care COPD patients: results of a cluster randomised trial. BMJ-British medical journal. doi: 10.1136/bmj.g5392
Kraijo, H., Brouwer, W.B.F., de Leeuw, R, Schrijvers, G. & Exel, N.J.A. van (2014). The perseverance time of informal carers of dementia patients: validation of a new measure to initiate transition of care at home to nursing home care. Journal of Alzheimers Disease, 40 (3), 631-642. doi: 10.3233/JAD-132420
Leunis, A., Redekop, W.K., Uyl – de Groot, C.A. & Lowenberg, B. (2014). Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study. European Journal of Haematology, 93 (3), 196-206. doi: http://dx.doi.org/10.1111/ejh.12324
Linden, N. van der, Gils, C.W.M. van, Pescott, C.P., Buter, J., Vergeer, M.R. & Uyl – de Groot, C.A. (2014). Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck. European Archives of Oto-Rhino-Laryngology.
Makai, P., Beckebans, F., Exel, N.J.A. van & Brouwer, W.B.F. (2014). Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O. PLoS One, 9 (3), e92016. doi: 10.1371/journal.pone.0092016
Mebratie, A., Poel, E. van de, Yilma, Z., Abebaw, D., Alemu, G. & Bedi, A. (2014). Healthcare-seeking behaviour in rural Ethiopia: evidence from clinical vignettes. BMJ Open, 4. doi: http://dx.doi.org/10.1136/bmjopen-2013-004020
Payakachat, N., Tilford, J.M., Kuhlthau, K.A., Exel, N.J.A. van, Kovacs, E, Bellando, J., Pyne, J.M. & Brouwer, W.B.F. (2014). Predicting Health Utilities for Children With Autism Spectrum Disorders. Autism Research, 7 (6), 649-663. doi: 10.1002/aur.1409
Péntek, M, Brodszky, V, Gulácsi, AL, Hajdú, O, Exel, N.J.A. van, Brouwer, W.B.F. & Gulácsi, L (2014). Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expectations, 17 (5), 696-709. doi: 10.1111/j.1369-7625.2012.00797.x
Péntek, M, Gulácsi, L, Rojkovich, B, Brodszky, V, Exel, N.J.A. van & Brouwer, W.B.F. (2014). Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. The European Journal Of Health Economics, 15 (S1), 83-92. doi: 10.1007/s10198-014-0597-1
Prick, B.W., Duvekot, J.J., Moer, P.E. van der, Gemund, N. van, Salm, P.C.M. van der, Jansen, A.J.G., Rhenen, D.J. van, Mol, BW & Uyl – de Groot, C.A. (2014). Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage. Vox Sanguinis, 107, 381-388. doi: 10.1111/vox.12181
Prick, B.W., Jansen, A.J.G., Steegers, E.A.P., Hop, W.C.J., Essink-Bot, M.L., Uyl – de Groot, C.A., Akkerboom, B.M.C., Alphen, M.M.A. van, Bloemenkamp, K.W.M., Boers, K.E., Bremer, H.A., Kwee, A., Loon, A.J. van, Metz, G.C.H., Papatsonis, D.N.M., Post, J.A.M. van der, Porath, M.M., Rijnders, R.J.P., Rejon-Parrilla, J.C., Nuijten, N, Redekop, W.K. & Gaultney, J.G. (2014). Economic evaluation of the use of a pharmacogenetic diagnostic test in schizophrenia. Health Policy and Technology, 3 (4), 314-324. doi: 10.1016/j.hlpt.2014.08.004
Roumen, F.J.M.E., Scheepers, H.C.J., Schippers, D.H., Schuitemaker, N.W.E., Stigter, R.H., Woiski, M.D., Mol, B.W.J., Rhenen, D.J. van & Duvekot, J.J. (2014). Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. Bjog-An International Journal of Obstetrics and Gynaecology, 121 (8), 1005-1014. doi: http://dx.doi.org/10.1111/1471-0528.12531
Redekop, W.K. (2014). Tools and techniques – statistics: comments on a cost-effectiveness study of TAVI for patients with inoperable aortic stenosis. EuroIntervention, 9 (10), 1241-1243. doi: 10.4244/EIJV9I10A208
Reeuwijk, K.G., Robroek, S., Hakkaart-van Roijen, L. & Burdorf, A. (2014). How Work Impairments and Reduced Work Ability are Associated with Health Care Use in Workers with Musculoskeletal Disorders, Cardiovascular Disorders or Mental Disorders. Journal of Occupational Rehabilitation. doi: http://dx.doi.org/10.1007/s10926-013-9492-3
Schols, A.M.W.J., Ferreira, I.M, Franssen, F.M., Gosker, H.R., Janssens, W, Muscaritoli, M, Pison, C, Rutten – van Molken, M.P.M.H., Slinde, F, Steiner, M.C., Tkacova, R & Singh, S.J. (2014). Nutritional assessment and therapy in COPD: a European Respiratory Society statement. European Respiratory Journal, 44 (6), 1504-1520. doi: 10.1183/09031936.00070914
Slok, A.H.M., Veen, J.C.C.M. in t, Chavannes, NH, Molen, T. van der, Rutten – van Molken, M.P.M.H., Kerstjens, H.A.M., Asijee, G.M., Salome, P.L., Holverda, S., Dekhuijzen, P.N.R., Schuiten, D., Breukelen, G. van, Kotz, D. & Schayck, C.P. van (2014). Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulmonary Medicine, 14 (131), 1-9. doi: 10.1186/1471-2466-14-131
Slok, A.H.M., Veen, JCCM in’t, Chavannes, NH, Molen, T. van der, Rutten – van Molken, M.P.M.H., Kerstjens, H.A.M., Salome, P.L., Holverda, S., Dekhuijzen, P.N.R., Schuiten, D., Asijee, G.M. & van Schayck, C.P. (2014). Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. Primary Care Respiratory Journal, 24. doi: 10.1038/npjpcrm.2014.21.
Sparrow, R., Poel, E. van de, Hadiwidjaja, G., Yumna, A., Warda, N. & Suryahadi, A. (2014). Coping with the economic consequences of ill health in Indonesia. Health Economics, 23 (6), 719-728. doi: http://dx.doi.org/10.1002/hec.2945
Tan, S.S., Geissler, A., Serden, L., Heurgren, M., Ineveld, B.M. van, Redekop, W.K. & Hakkaart-van Roijen, L. (2014). DRG systems in Europe: variations in cost accounting systems among 12 countries. European Journal of Public Health, 1022-1027. doi: http://dx.doi.org/10.1093
Tan, S.S., Wiegerink, D.J.H.G., Ketelaar, M, Smits, D.W., Voorman, J.M., Vos, R.C., Twisk, J.W.R. & Roebroeck, M.E. (2014). Developmental trajectories of social participation in individuals with cerebral palsy. Developmental Medicine & Child Neurology, 56 (4), 370-377. doi: http://dx.doi.org/10.1111/dmcn.12343
Tielen, M., Exel, N.J.A. van, Laging, M., Beck, D.K., Khemai, R, Gelder, T. van, Betjes, M.G., Weimar, W. & Massey, E.K. (2014). Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study.
Tsiachristas, A., Cramm, J.M., Nieboer, A.P. & Rutten – van Molken, M.P.M.H. (2014). Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants. Cost Effectiveness and Resource Allocation, 12:17. doi: doi: 10.1186/1478-7547-12-17.
Tsiachristas, A., Hipple Walters, B., Adams, S.A., Bal, R.A. & Rutten – van Molken, M.P.M.H. (2014). Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands. Bmc Health Services Research, 14, 518. doi: 10.1186/s12913-014-0518-0
Tsiachristas, A. & Rutten – van Molken, M.P.M.H. (2014). Exploring the variability of patient costs in disease management programs: A hierarchical modelling approach. Applied Economics, 46 (9), 940-951. doi: 10.1080/00036846.2013.864044
Utens, C.M.A., Goossens, L.M.A., van Schayck, C.P., Rutten – van Molken, M.P.M.H., Smeenk, F.W., van Vliet, M., Seezink, W. & DeMunck, D.R. (2014). Informal caregiver strain, preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: results of a randomised controlled trial. International Journal of Nursing Studies, 51 (8), 1093-1102. doi: 10.1016/j.ijnurstu.2014.01.002
Uyl-de Groot, C.A. & Stierman, D.T. (2014). Resultaten monitor overheveling TNF-alfaremmers, groeihormonen, oncologische- en andere geneesmiddelen. Rotterdam: Institute for Medical Technology Assessment / Instituut voor Beleid en Management Gezondheidszorg Erasmus Universiteit Rotterdam.
Uyl – de Groot, C.A., Vries, E.G.E. de, Verweij, J. & Sullivan, R. O’ (2014). Dispelling the myths around cancer care delivery: It’s not all about costs. Journal of Cancer Policy, 2, 22-29. doi: 10.1016/j.jcpo.2014.01.001
Vaidya, A., Severens, J.L., Bongaerts, B.W.C, Cleutjens, C.B.J.M., Nelemans, P.J., Hofstra, L, Dieijen-Visser, M.P. van & Biessen, E.A.L. (2014). High-sensitive Troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BioMed Central. doi: http://dx.doi.org/10.1186/1471-2261-14-77
Vataire, A.L., Aballea, S., Antonanzas, F., Hakkaart-van Roijen, L., Lam, R.W., McCrone, P., Persson, U. & Toumi, M (2014). Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder. Value in Health, 17 (2), 183-195. doi: 10.1016/j.jval.2013.11.012
van Veen-Berkx, E., Bitter, J, Elkhuizen, S.G., Buhre, WF, Kalkman, CJ, Gooszen, H.G. & Kazemier, G. (2014). The influence of anesthesia-controlled time on operating room. Canadian Journal of Anaesthesia-Journal Canadien d’ Anesthésie. doi: http://dx.doi.org/10.1007/s12630-014-0134-9
van Veen-Berkx, E., Bitter, J, Elkhuizen, S.G., Buhre, WF, Kalkman, CJ, Gooszen, H.G. & Kazemier, G. (2014). Comment on research article entitled “Variability of Subspecialty-Specific Anesthesia-. Journal of Medical Systems, 38 (11), 50. doi: 10.1007/s10916-014-0051-z
van Veen-Berkx, E., Elkhuizen, S.G., Kalkman, CJ, Buhre, WF & Kazemier, G. (2014). Successful interventions to reduce first-case tardiness in. American Journal of Surgery.
Vemer, P., Goossens, L.M.A. & Rutten – van Molken, M.P.M.H. (2014). Not Simply More of the Same: Distinguishing between Patient Heterogeneity and Parameter Uncertainty. Medical Decision Making, 34 (8), 1048-1058. doi: 10.1177/0272989X14550499
Verhoef, T.I., Redekop, W.K., Bouvy, ML, Dorenbos, B., Karwar, Z., van Schie, R.M., de Boer, A. & Maitland-van der Zee, A.H. (2014). Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users. British Journal of Clinical Pharmacology, 78 (2), 422-429. doi: 10.1111/bcp.12346
Verhoef, T.I., Redekop, W.K., Daly, A.K., van Schie, R.M., de Boer, A. & Maitland-van der Zee, A.H. (2014). Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. British Journal of Clinical Pharmacology, 77 (4), 626-641. doi: 10.1111/bcp.12220
Verhoef, T.I., Redekop, W.K., Hasrat, F., de Boer, A. & Maitland-van der Zee, A.H. (2014). Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings. American Journal of Cardiovascular Drugs, 14 (6), 451-462. doi: 10.1007/s40256-014-0092-1
Versteeg, H, Pedersen, S.S., Mastenbroek, MH, Redekop, W.K., Schwab, J.O., Mabo, P. & Meine, M (2014). Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study. Netherlands Heart Journal, 22 (10), 423-428. doi: 10.1007/s12471-014-0587-z
de Vries, E., Uribe, C., Pardo, C, Lemmens, V, Poel, E. van de & Forman, D. (2014). Gastric cancer survival and affiliation to health insurance in a middle-income setting. Cancer Epidemiology. doi: 10.1016/j.canep.2014.10.012
Wagstaff, A., Bredenkamp, C. & Buisman, L.R. (2014). Progress on Global Health Goals: are the Poor Being Left Behind? World Bank Research Observer, 29 (2), 137-162. doi: http://dx.doi.org/10.1093/wbro/lku008